Ad
related to: novartis ag company- Contact Us
Contact a PYLARIFY sales
representative to stay updated.
- Resources for PYLARIFY
Discover downloadable guides for
health care professionals.
- PYLARIFY Imaging Sites
Find or register a PYLARIFY
imaging site.
- PYLARIFY Case Studies
Review actual case study
findings for PYLARIFY.
- Contact Us
Search results
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 10 hours agoNovartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 10 hours agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
Mather Group LLC. Acquires 1,712 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 1 day agoMather Group LLC. boosted its holdings in Novartis AG (NYSE:NVS – Free Report) by 22.1% in the fourth quarter, according to its most recent 13F filing with ...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 1 day agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 3 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Amgen, Sandoz Settle Clash Over Biosimilars of Blockbuster Drugs
Bloomberg Law· 3 days agoand Sandoz Group AG settled a patent-infringement lawsuit over biosimilar versions of Amgen’s Prolia and Xgeva bone-strengthening treatments, according to a New Jersey federal ...
Incyte misses quarterly profit on weak sales of lead drug
Reuters via AOL· 2 days agoThe company is working on strengthening its pipeline to counter competition from newly approved drugs, which could impact sales of Jakafi, the company's ...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 2 days agoThe company obtained accelerated approval for Zynyz to treat metastatic or recurrent locally...
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
WFRV 5 Green Bay· 2 days agoBio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors, April ...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 2 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...